NxStage Medical Inc.
NXTM
NXTM was delisted on the 21st of February, 2019.
156 hedge funds and large institutions have $1.6B invested in NxStage Medical Inc. in 2016 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 50 increasing their positions, 56 reducing their positions, and 19 closing their positions.
53% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 19
25% more funds holding in top 10
Funds holding in top 10: 8 → 10 (+2)
16% more capital invested
Capital invested by funds: $1.38B → $1.6B (+$223M)
6% more funds holding
Funds holding: 147 → 156 (+9)
11% less repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 56
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
+$41.7M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$40.4M |
| 3 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
+$20.1M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$10.5M |
| 5 |
Goldman Sachs
New York
|
+$9.43M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
-$18.1M |
| 2 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$14.7M |
| 3 |
Millennium Management
New York
|
-$13.5M |
| 4 |
DM
Deerfield Management
New York
|
-$9.47M |
| 5 |
William Blair & Company
Chicago,
Illinois
|
-$7.66M |
NXTM Hedge Fund Activity: Q3 2016 in Review
156 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q3 2016, worth a combined $1.6B — up 16% from $1.38B a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new NXTM positions and 19 closed out — a net gain of 10 holders — while 50 added to existing stakes and 56 trimmed.
The largest buyer was Victory Capital Management, opening a new position worth an estimated $41.7M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $18.1M sold.
- 156 institutional investors held NxStage Medical Inc. (NXTM) as of Q3 2016, up from 147 in Q2 2016.
- Funds reported $1.6B of NxStage Medical Inc. stock for Q3 2016, up 16% quarter-over-quarter.
- 29 funds opened new NxStage Medical Inc. positions in Q3 2016 and 19 closed out, a net change of +10 holders.
- The largest NxStage Medical Inc. buyer in Q3 2016 was Victory Capital Management, an estimated $41.7M added.
- The largest NxStage Medical Inc. seller in Q3 2016 was Consonance Capital Management, an estimated $18.1M sold.
Based on aggregated 13F filings for Q3 2016.